Stem cell therapy: a new therapeutic option for cardiovascular diseases

NH Goradel, FG Hour, B Negahdari… - Journal of cellular …, 2018 - Wiley Online Library
Cardiovascular diseases are known as one of major causes of morbidity and mortality
worldwide. Despite the many advancement in therapies are associated with cardiovascular …

Graphene nanomaterials as biocompatible and conductive scaffolds for stem cells: impact for tissue engineering and regenerative medicine

F Menaa, A Abdelghani… - Journal of tissue …, 2015 - Wiley Online Library
The discovery of the interesting intrinsic properties of graphene, a two‐dimensional
nanomaterial, has boosted further research and development for various types of …

Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms

JM Duran, CA Makarewich, TE Sharp… - Circulation …, 2013 - Am Heart Assoc
Rationale: Autologous bone marrow–derived or cardiac-derived stem cell therapy for heart
disease has demonstrated safety and efficacy in clinical trials, but functional improvements …

Cardiopoietic programming of embryonic stem cells for tumor-free heart repair

A Behfar, C Perez-Terzic, RS Faustino… - The Journal of …, 2007 - rupress.org
Embryonic stem cells have the distinct potential for tissue regeneration, including cardiac
repair. Their propensity for multilineage differentiation carries, however, the liability of …

Cardiac tumorgenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction

RPH Ahmed, M Ashraf, S Buccini, J Shujia… - Regenerative …, 2011 - Taylor & Francis
Aim: Genetic reprogramming of somatic cells with stemness genes to restore their
pluripotent status is being studied extensively to generate pluripotent stem cells as an …

Treatment of oxidative stress with exosomes in myocardial ischemia

Y Liu, M Wang, Y Liang, C Wang, K Naruse… - International journal of …, 2021 - mdpi.com
A thrombus in a coronary artery causes ischemia, which eventually leads to myocardial
infarction (MI) if not removed. However, removal generates reactive oxygen species (ROS) …

Influence of nanomaterials on stem cell differentiation: designing an appropriate nanobiointerface

I Ilie, R Ilie, T Mocan, D Bartos… - International journal of …, 2012 - Taylor & Francis
During the last decade, due to advances in functionalization chemistry, novel
nanobiomaterials with applications in tissue engineering and regenerative medicine have …

[HTML][HTML] Stem cell therapy in heart failure: Where do we stand today?

N Nair, E Gongora - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2020 - Elsevier
Heart failure is a global epidemic that drastically cuts short longevity and compromises
quality of life. Approximately 6 million Americans≥ 20 years of age carry a diagnosis of …

The current status of stem cell therapy in ischemic heart disease

RE Michler - Journal of cardiac surgery, 2018 - Wiley Online Library
The last decade has witnessed the publication of a number of stem cell clinical trials,
primarily using bone marrow‐derived cells as the injected cell. Much has been learned …

Isoflurane Postconditioning Protects Against Reperfusion Injury by Preventing Mitochondrial Permeability Transition via an Endothelial Nitric Oxide Synthase …

ZD Ge, D Pravdic, M Bienengraeber… - …, 2010 - pmc.ncbi.nlm.nih.gov
Background The role of endothelial nitric oxide synthase (eNOS) in isoflurane
postconditioning (IsoPC)-elicited cardioprotection is poorly understood. We addressed this …